ANL 10.30 Decreased By ▼ -0.03 (-0.29%)
ASC 9.03 Decreased By ▼ -0.04 (-0.44%)
ASL 11.15 Decreased By ▼ -0.05 (-0.45%)
AVN 77.90 Decreased By ▼ -0.48 (-0.61%)
BOP 5.42 Decreased By ▼ -0.01 (-0.18%)
CNERGY 5.35 Decreased By ▼ -0.02 (-0.37%)
FFL 6.65 Increased By ▲ 0.02 (0.3%)
FNEL 5.84 Decreased By ▼ -0.11 (-1.85%)
GGGL 11.02 Decreased By ▼ -0.04 (-0.36%)
GGL 16.51 Decreased By ▼ -0.02 (-0.12%)
GTECH 8.46 Increased By ▲ 0.05 (0.59%)
HUMNL 7.14 Decreased By ▼ -0.02 (-0.28%)
KEL 3.03 Decreased By ▼ -0.06 (-1.94%)
KOSM 3.20 Increased By ▲ 0.16 (5.26%)
MLCF 27.30 Increased By ▲ 0.30 (1.11%)
PACE 3.00 No Change ▼ 0.00 (0%)
PIBTL 6.15 Increased By ▲ 0.08 (1.32%)
PRL 17.90 Decreased By ▼ -0.30 (-1.65%)
PTC 6.97 Decreased By ▼ -0.05 (-0.71%)
SILK 1.19 Increased By ▲ 0.03 (2.59%)
SNGP 34.34 Decreased By ▼ -0.07 (-0.2%)
TELE 10.80 Decreased By ▼ -0.23 (-2.09%)
TPL 9.12 Increased By ▲ 0.07 (0.77%)
TPLP 20.15 Increased By ▲ 0.11 (0.55%)
TREET 29.24 Decreased By ▼ -0.26 (-0.88%)
TRG 77.44 Increased By ▲ 0.39 (0.51%)
UNITY 20.11 Decreased By ▼ -0.13 (-0.64%)
WAVES 12.80 Increased By ▲ 0.10 (0.79%)
WTL 1.36 Decreased By ▼ -0.01 (-0.73%)
YOUW 4.97 Increased By ▲ 0.17 (3.54%)
BR100 4,105 Increased By 26.1 (0.64%)
BR30 15,117 Decreased By -4.3 (-0.03%)
KSE100 41,479 Increased By 181.2 (0.44%)
KSE30 15,786 Increased By 89.3 (0.57%)
World

WHO says awaits EMA, FDA reviews of J&J COVID-19 vaccine, monitoring global data

  • U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's COVID-19 vaccine after six women under 50 given the shot developed rare blood clots.
Updated 14 Apr, 2021

GENEVA: The World Health Organization, asked about reports of rare blood clots after vaccination with the Johnson & Johnson COVID-19 shot, told Reuters on Tuesday that it awaited reviews by the U.S. and European regulators and was monitoring global data.

"We're watching closely, waiting for EMA (European Medicines Agency) and FDA (U.S. Food and Drug Administration) reviews and monitoring the global database of adverse event reports to see if there have been cases anywhere else," the WHO said in an email reply. "It will take a little time to review the data."

U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's COVID-19 vaccine after six women under 50 given the shot developed rare blood clots.

Following the news, J&J said it was delaying the rollout of the vaccine to Europe, a week after regulators there said they were reviewing rare blood clots in four recipients of the shot in the United States.

Comments

Comments are closed.